Procter & Gamble Stock Has Risen 1.7x Since 2018 – Well Deserved?
Procter & Gamble’s (NYSE: PG) stock price grew 70% from $92 in 2018 end to around $156 currently, primarily due to a significant jump in the P/S multiple. Steady revenue growth has also helped, and stock price gains were further supported by a slight decrease in the outstanding share count.
In our interactive dashboard, Why Procter & Gamble Stock Moved: PG Stock Has Gained 70% Since 2018, we break down the factors behind this move.
(A) PG’s Total Revenue has grown 14% from $66.8 billion in 2018 to over $76 billion in 2020, and currently stands at around the same level
- PG’s total revenue has grown from $66.8 billion in 2018 to $76.1 billion in 2020 (PG’s fiscal year ends in June), led primarily by a steady rise in fabric and home care sales, and a revival in beauty product sales after the pandemic.
- These products have helped Procter & Gamble post consistent sales growth in both the United States and international markets.
- Additionally, PG’s health care, and baby, feminine and family segments have also seen steady growth over the years, while the grooming segment has seen the slowest growth.
- Additionally, for details about PG revenues and comparison to peers, see Procter & Gamble (PG) Revenue Comparison
- Should You Buy Colgate-Palmolive Stock At $80?
- Here’s A Better Pick Over Procter & Gamble Stock
- Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?
- This Pharmaceuticals Company Looks To Be A Better Pick Over Procter & Gamble Stock
- Consistent Sales Growth Has Helped Procter & Gamble Stock To Match The Market Returns
- Procter & Gamble Stock Has Outperformed The S&P 500 Since 2017 End: Here’s Why
(B) Revenue per share (RPS) increased from $25.70 in 2018 to $30.27 in 2021 and currently stands around the same level
- PG revenue jumped from $66.8 billion in 2018 to $76.1 billion in 2021, while the outstanding share count first increased from 2.6 billion in 2018 to 2.7 billion in 2019, before dropping to around 2.5 billion currently.
- Due to this, RPS has risen from $25.70 in FY ’18 to over $30 currently.
(C) Price-To-Sales (P/S) multiple for PG has risen steadily since 2018 and is more than 1.5x that of 2018 levels, going from 3.3x in 2018 to 5.2x in late-2021
- Procter & Gamble’s exceptional performance since 2018-end has seen its P/S multiple rise from 3.3x in 2018 to over 5x currently.
- PG has also reported strong Q2 ’21 earnings recently, with revenue rising from $19.7 billion in Q2 ’20 to $20.9 billion in Q2 ’21 and EPS rising from $1.53 to $1.72 over this period.
- This sustained performance means that PG warrants its steadily growing PS multiple.
- For additional details about the company’s historical returns and comparison to peers, see Procter & Gamble (PG) Stock Return.
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.
|S&P 500 Return||0%||-8%||95%|
|Trefis MS Portfolio Return||0%||-10%||254%|
 Month-to-date and year-to-date as of 3/1/2022
 Cumulative total returns since the end of 2016
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates